Skip to main content
Clinical Trials/NCT03643718
NCT03643718RecruitingNot Applicable

Web-based International Register of Emergency Surgery and Trauma

A.O. Ospedale Papa Giovanni XXIII1 site in 1 country10,000 target enrollmentStarted: July 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
10,000
Locations
1
Primary Endpoint
Rate of patients treated with conservative treatment

Study Overview

Brief Summary

The WIRES-T project (Web-based International Registry of Emergency General Surgery and Trauma) has been set up to allow to all the EGS (Emergency General Surgery) and Trauma surgeons to register their activity and to obtain a worldwide register of traumatic and non traumatic surgical emergencies. This will give the opportunity to evaluate results on a macro-data basis and to give index allowing stratifying, evaluating and improving the outcomes.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients affected by an acute surgical disease
  • •Patients with indication to be referred to the emergency surgeon attention
  • •Patients to be operated or to be treated with non-operative approach without surgical intervention

Exclusion Criteria

  • •Patients not affected by an acute surgical disease
  • •Patients without indication to be referred to the emergency surgeon attention

Outcomes

Primary Outcomes

Rate of patients treated with conservative treatment

Time Frame: Until hospital discharge, approximately 2 weeks

Evaluate the conservative treatment rate for each different disease according to patient's characteristics and the enviroinment.

Rate of patients treated with surgery

Time Frame: Until hospital discharge, approximately 2 weeks

Evaluate the rate of operative treatment for each different disease according to the different enviroment; for each intervention the surgical approach (laparotomic, mini-invasive, laparoscopic) will be evaluated.

Secondary Outcomes

  • Morbidity(Until hospital discharge, approximately 2 weeks)
  • Mortality(Until hospital discharge, approximately 2 weeks)

Investigators

Sponsor
A.O. Ospedale Papa Giovanni XXIII
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Federico Coccolini, MD

Attending Surgeon

University of Pisa

Study Sites (1)

Loading locations...

Similar Trials